High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study

Background and Aims: Inflammation is involved in the pathophysiology of ischemic stroke. The aim of this prospective study was to evaluate the association of hs-CRP with incident ischemic stroke in patients with nonalcoholic fatty liver disease (NAFLD). Methods: A sample of 318 participants without...

Full description

Bibliographic Details
Main Authors: He, Q. (Author), Jia, M. (Author), Shi, Y. (Author), Wang, M. (Author), Wang, Y. (Author), Yuan, T. (Author), Zhang, L. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Online Access:View Fulltext in Publisher
LEADER 02567nam a2200205Ia 4500
001 0.1155-2022-9711712
008 220421s2022 CNT 000 0 und d
020 |a 20402309 (ISSN) 
245 1 0 |a High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study 
260 0 |b NLM (Medline)  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1155/2022/9711712 
520 3 |a Background and Aims: Inflammation is involved in the pathophysiology of ischemic stroke. The aim of this prospective study was to evaluate the association of hs-CRP with incident ischemic stroke in patients with nonalcoholic fatty liver disease (NAFLD). Methods: A sample of 318 participants without previous strokes was included in this study. Hs-CRP levels and other potential confounding factors were measured at baseline. NAFLD was performed by abdominal ultrasound after excluding secondary causes for fat accumulation. According to baseline hs-CRP concentrations, participants were categorized into 3 groups: level 1 (<1.0 mg/L), level 2 (1.0 to <3.0 mg/L), and level 3 (≥3.0 mg/L). The outcome of interest was the first occurrence of an ischemic stroke. Cox proportional hazards models were used to analyze hazard ratios (HRs) and 95% confidence intervals (CIs) of incident ischemic stroke, after adjusting for potential confounders. Results: The mean age of 318 participants with NAFLD was 71.1 ± 6.7 years, and 55.3% of them were male. Among 318 individuals with NAFLD, 115 (36.2%) of them had an hs-CRP value <1 mg/L (level 1), 105 (33.0%) had an hs-CRP value between 1 and 3 mg/L (level 2), and 98 (30.8%) belonged to level 3 (hs-CRP ≥3 mg/L). Over a median of 5.60 years of follow-up, 47 incident ischemic stroke events were documented in 318 patients with NAFLD. After full adjustment for confounding factors, compared with participants in the level 1 group (hs-CRP<1.0 mg/L), the HRs of those in the level 2 group (1.0 to <3.0 mg/L) and the level 3 group (≥3.0 mg/L) were 1.77 (95% CI: 0.94-2.98) and 2.45 (95% CI: 1.37-5.77) for developing ischemic stroke, respectively. Conclusions: Elevated hs-CRP levels were associated with an increased risk of ischemic stroke among patients with NAFLD. Copyright © 2022 Meng Jia et al. 
700 1 0 |a He, Q.  |e author 
700 1 0 |a Jia, M.  |e author 
700 1 0 |a Shi, Y.  |e author 
700 1 0 |a Wang, M.  |e author 
700 1 0 |a Wang, Y.  |e author 
700 1 0 |a Yuan, T.  |e author 
700 1 0 |a Zhang, L.  |e author 
773 |t Journal of healthcare engineering